Pediatric ventricle assist device (VAD) manufacturer Berlin Heart is making more, but new tariffs might mean hospitals can't ...

Johnson & Johnson (NYSE:JNJ) reported Q2 2025 earnings on July 16, 2025, posting sales of $23.7 billion (up 4.6%), with adjusted EPS of $2.77 and net earnings of $5.5 billion. Management raised ...

Johnson & Johnson stands alone as a leader across the major healthcare industries. It maintains a diverse revenue base, a developing research pipeline, and exceptional cash flow generation that ...

Johnson & JohnsonJNJ stock jumped Wednesday after the Dow Jones health behemoth raised its 2025 guidance in the wake of a bullish second-quarter report.For the year, J&J now expects adjusted earnings ...

Discover Johnson & Johnson's Q2 2025 earnings insights with raised guidance and strategic growth in Oncology & MedTech.

The FDA has placed pediatric ventricular assist bypass devices (product code DSQ) on its medical device shortage list.

Johnson & Johnson (NYSE:JNJ) on Wednesday reported a second-quarter 2025 adjusted earnings of $2.77 per share, down 1.8% year ...

Shares of Johnson & Johnson climbed 6.8% in morning trading, enough to pace the S&P 500 index's SPX gainers. They were also headed for their biggest one-day gain and best postearnings reaction since ...

Intuitive Surgical, Inc. (NASDAQ:ISRG) is one of the Best Non-Mega Cap NASDAQ Stocks to Buy Right Now. BTIG analyst Ryan ...

The Motley Fool. DATE Wednesday, July 16, 2025 at 8:30 a.m. ET CALL PARTICIPANTS Chairman and Chief Executive Officer — ...

Momentum in Johnson & Johnson’s cardiovascular business continues, while the company looks to regain its footing in the ...

Ensure your AI systems in MedTech meet compliance standards. Join our webinar on AI governance strategy and regulatory best practices.